Trial to Evaluate Paclitaxel Plus RAD001 in Urothelial Carcinoma

Summary

This is a single arm open- label phase II- trial evaluating safety and efficacy of paclitaxel and RAD001 in patients with metastatic urothelial bladder cancer who failed prior platin-based systemic therapy.

Timeline

Start

2009-07

Primary completion

2013-01

Completion

2013-09

Outcome

Outcome not reported

Stopped (Enrollment): “delayed recruitment”

Drugs

Indications